Home - Products - Apoptosis - TNF - Physcion 8-O-β-D-glucopyranoside

Physcion 8-O-β-D-glucopyranoside

CAS No. 23451-01-6

Physcion 8-O-β-D-glucopyranoside( Physcion 8-O-beta-D-monoglucoside )

Catalog No. M29212 CAS No. 23451-01-6

Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 155 In Stock
10MG 231 In Stock
25MG 377 In Stock
50MG 556 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Physcion 8-O-β-D-glucopyranoside
  • Note
    Research use only, not for human use.
  • Brief Description
    Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
  • Description
    Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.(In Vitro):Physcion 8-O-β-D-glucopyranoside inhibits TNF-α±-induced cytotoxicity and apoptosis in L929 cells via TNF-R1.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Physcion 8-O-beta-D-monoglucoside
  • Pathway
    Apoptosis
  • Target
    TNF
  • Recptor
    TNF
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23451-01-6
  • Formula Weight
    446.408
  • Molecular Formula
    C22H22O10
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 25 mg/mL (56.00 mM)
  • SMILES
    COc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Brentuximab

    Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkin's lymphoma.

  • XYLOBIOSE

    XYLOBIOSE ia a natural productand exhibited therapeutic potential for treating obesity which involved suppression of fat deposition and obesity-related metabolic disorders.

  • 2-Fucosyllactose

    2'-Fucosyllactose (2'-FL) is an oligosaccharide that could be derived from human milk.